The 300U pump offers 50% more reservoir capacity than standard 200-unit models, addressing a frequent pain point for users who prioritize longer intervals between device changes. Despite the increased volume, the hardware retains the discreet, body-worn form factor characteristic of the broader TouchCare Nano System. CEO Scott Yang noted that the German launch aligns with the company’s push to expand its European commercial footprint through established reimbursement frameworks and clinical partnerships.

Integration remains a cornerstone of the offering. The pump functions within the TouchCare Nano ecosystem, which combines continuous glucose monitoring with the proprietary APGO automated insulin delivery algorithm. A notable feature is the Auto Meal Handling function, designed to simplify glucose management by allowing users to categorize meals without performing exhaustive carbohydrate calculations. With the company already holding EU MDR Class III certification, the 300U rollout represents a strategic effort to solidify its presence in one of Europe’s most competitive diabetes technology sectors.